Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Nucleotide
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Medical applications of synthetic nucleotides== The applications of synthetic nucleotides vary widely and include disease diagnosis, treatment, or precision medicine. # '''Antiviral or Antiretroviral agents:''' several nucleotide derivatives have been used in the treatment against infection with [[Hepatitis]] and [[HIV]].<ref>{{cite journal | vauthors = Ramesh D, Vijayakumar BG, Kannan T | title = Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders | journal = European Journal of Medicinal Chemistry | volume = 207 | pages = 112801 | date = December 2020 | pmid = 32927231 | doi = 10.1016/j.ejmech.2020.112801 | s2cid = 221724578 }}</ref><ref>{{cite journal | vauthors = Ramesh D, Vijayakumar BG, Kannan T | title = Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections | journal = ChemMedChem | volume = 16 | issue = 9 | pages = 1403β1419 | date = May 2021 | pmid = 33427377 | doi = 10.1002/cmdc.202000849 | url = https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202000849 | access-date = 13 March 2021 | url-status = dead | s2cid = 231576801 | archive-url = https://web.archive.org/web/20211214220544/https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202000849 | archive-date = 14 December 2021 | url-access = subscription }}</ref> Examples of direct nucleoside analog reverse-transcriptase inhibitors ([[Reverse-transcriptase inhibitor|NRTIs]]) include [[Tenofovir disoproxil]], [[Tenofovir alafenamide]], and [[Sofosbuvir]]. On the other hand, agents such as [[Mericitabine]], [[Lamivudine]], [[Entecavir]] and [[Telbivudine]] must first undergo metabolization via phosphorylation to become activated. # '''Antisense oligonucleotides (ASO)''': synthetic [[Oligonucleotide|oligonucleotides]] have been used in the treatment of rare heritable diseases since they can bind specific [[RNA]] transcripts and ultimately modulate protein expression. [[Spinal muscular atrophy]], [[ALS|amyotrophic lateral sclerosis]], [[Familial hypercholesterolemia|homozygous familial hypercholesterolemia]], and [[Primary hyperoxaluria|primary hyperoxaluria type 1]] are all amenable to ASO-based therapy.<ref>{{cite journal | vauthors = Lauffer MC, van Roon-Mom W, Aartsma-Rus A | title = Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders | journal = Communications Medicine | volume = 4 | issue = 1 | pages = 6 | date = January 2024 | pmid = 38182878 | pmc = 10770028 | doi = 10.1038/s43856-023-00419-1 }}</ref> The application of oligonucleotides is a new frontier in precision medicine and management of conditions which are untreatable. # '''Synthetic guide RNA (gRNA)''': synthetic nucleotides can be used to design [[Guide RNA|gRNA]] which are essential for the proper function of gene-editing technologies such as [[CRISPR gene editing|CRISPR-Cas9]].
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)